The Klinique Med Stock Return On Equity

KLINIQ Stock   31.75  1.00  3.05%   
The Klinique Med fundamentals help investors to digest information that contributes to Klinique Med's financial success or failures. It also enables traders to predict the movement of Klinique Stock. The fundamental analysis module provides a way to measure Klinique Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klinique Med stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

The Klinique Med Company Return On Equity Analysis

Klinique Med's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Klinique Med Return On Equity

    
  0.95  
Most of Klinique Med's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The Klinique Med is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, The Klinique Med has a Return On Equity of 0.9513. This is 73.57% lower than that of the Consumer Cyclical sector and 97.24% lower than that of the Personal Services industry. The return on equity for all Thailand stocks is notably lower than that of the firm.

Klinique Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klinique Med's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klinique Med could also be used in its relative valuation, which is a method of valuing Klinique Med by comparing valuation metrics of similar companies.
Klinique Med is currently under evaluation in return on equity category among its peers.

Klinique Fundamentals

About Klinique Med Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze The Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Klinique Stock

Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.